Pulmonary Hypertension Trial, Recruiting NCT07495774 Sponsor: Guangdong Provincial People's Hospital Condition: Pulmonary Hypertension
Back to Pulmonary Hypertension

Pulmonary Hypertension Trial, Recruiting

NCT07495774
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children and teenagers who were diagnosed with pulmonary hypertension (high blood pressure in the lungs) before the age of 18
  • People whose pulmonary hypertension diagnosis was made according to the standard medical guidelines used at the time they joined the study
  • People who are enrolled at one of the medical centres taking part in this registry
  • People (or their parent or legal guardian) who have agreed to take part by signing a consent form
  • People who are able to attend follow-up appointments over a period of time

Who may not be able to join:

  • People whose pulmonary hypertension diagnosis cannot be confirmed because there is not enough medical information or test data available
  • People who are unwilling or unable to provide consent to participate (or whose parent or legal guardian is unwilling or unable to do so)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Zhi-Cheng Jing, Prof., Guangdong Provincial People's Hospital

Phone: +86-18629534652

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Guangdong Provincial People's Hospital
Registry
ClinicalTrials.gov
Start date
4 January 2006
Est. completion
31 December 2032

Where this trial is recruiting

🇨🇳 China

Primary endpoints

death; transplantation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov